Evidence map›Paper›PMID 30635573›Full record

ArticleNature communications2019

Lin28 and let-7 regulate the timing of cessation of murine nephrogenesis.

Alena V Yermalovich, Jihan K Osborne, Patricia Sousa, Areum Han, Melissa A Kinney, Michael J Chen, Daisy A Robinton, Helen Montie, Dan S Pearson, Sean B Wilson and 3 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Nature communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 63 citations in OpenAlex.

  1. Article
  2. Epigenetic regulation of kidney development.Nature reviews. Nephrology · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Nephron-SpecificInternational journal of biological sciences · 2024
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Alena V YermalovichDivision of Pediatric Hematology/Oncology, Children's Hospital Boston, Boston, MA, 02115, USA.
Jihan K OsborneDivision of Pediatric Hematology/Oncology, Children's Hospital Boston, Boston, MA, 02115, USA.
Patricia SousaDivision of Pediatric Hematology/Oncology, Children's Hospital Boston, Boston, MA, 02115, USA.
Areum HanDivision of Pediatric Hematology/Oncology, Children's Hospital Boston, Boston, MA, 02115, USA.
Melissa A KinneyDivision of Pediatric Hematology/Oncology, Children's Hospital Boston, Boston, MA, 02115, USA.
Michael J ChenDivision of Pediatric Hematology/Oncology, Children's Hospital Boston, Boston, MA, 02115, USA.ORCID http://orcid.org/0000-0001-9117-0328
Daisy A RobintonDivision of Pediatric Hematology/Oncology, Children's Hospital Boston, Boston, MA, 02115, USA.
Helen MontieDivision of Pediatric Hematology/Oncology, Children's Hospital Boston, Boston, MA, 02115, USA.
Dan S PearsonDivision of Pediatric Hematology/Oncology, Children's Hospital Boston, Boston, MA, 02115, USA.
Sean B WilsonMurdoch Childrens Research Institute, Royal Children's Hospital, 50 Flemington Rd, Parkville, Melbourne, 3052, Australia.ORCID http://orcid.org/0000-0002-8994-0781
Alexander N CombesMurdoch Childrens Research Institute, Royal Children's Hospital, 50 Flemington Rd, Parkville, Melbourne, 3052, Australia.
Melissa H LittleMurdoch Childrens Research Institute, Royal Children's Hospital, 50 Flemington Rd, Parkville, Melbourne, 3052, Australia. Melissa.Little@mcri.edu.au.ORCID http://orcid.org/0000-0003-0380-2263
George Q DaleyDivision of Pediatric Hematology/Oncology, Children's Hospital Boston, Boston, MA, 02115, USA. George_Daley@hms.harvard.edu.
Boston Children's Hospital · USRoyal Children's Hospital · AUThe Royal Melbourne Hospital · AU

Funding

Medical Scientist Training ProgramT32GM007753 · NIGMS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI WALENSKY, LOREN DAVID · 1985 to 2021
$50.0M
Understanding the role of the lin28 paralogs and branching morphogenesisR01GM107536 · NIGMS · BOSTON CHILDREN'S HOSPITAL · PI DALEY, GEORGE Q · 2014 to 2017
$1.9M
The role of CMTR2 in Lung CancerK00CA212487 · NCI · DANA-FARBER CANCER INST · PI YERMALOVICH, ALENA · 2019 to 2022
$374k
The role of Lin28/let 7 pathway in Wilms' tumorF99CA212487 · NCI · HARVARD UNIVERSITY · PI YERMALOVICH, ALENA · 2016 to 2017
$65k
NCI NIH HHS F99 CA212487NCI NIH HHS K00 CA212487NIGMS NIH HHS R01 GM107536NIGMS NIH HHS T32 GM007753
6 · The paper itself

Abstract

In humans and in mice the formation of nephrons during embryonic development reaches completion near the end of gestation, after which no new nephrons are formed. The final nephron complement can vary 10-fold, with reduced nephron number predisposing individuals to hypertension, renal, and cardiovascular diseases in later life. While the heterochronic genes lin28 and let-7 are well-established regulators of developmental timing in invertebrates, their role in mammalian organogenesis is not fully understood. Here we report that the Lin28b/let-7 axis controls the duration of kidney development in mice. Suppression of let-7 miRNAs, directly or via the transient overexpression of LIN28B, can prolong nephrogenesis and enhance kidney function potentially via upregulation of the Igf2/H19 locus. In contrast, kidney-specific loss of Lin28b impairs renal development. Our study reveals mechanisms regulating persistence of nephrogenic mesenchyme and provides a rationale for therapies aimed at increasing nephron mass.

Indexed as

AnimalsDNA-Binding ProteinsFemaleInsulin-Like Growth Factor IIKidneyKidney Function TestsMaleMice, TransgenicMicroRNAsRNA-Binding ProteinsRNA, Long NoncodingDNA-Binding ProteinsH19 long non-coding RNAIGF2 protein, mouseInsulin-Like Growth Factor IILin28b protein, mouseLin-28 protein, mouseMicroRNAsmirnlet7 microRNA, mouseRNA-Binding ProteinsRNA, Long Noncoding

Identifiers

PMID30635573
PMCPMC6329821
OpenAlexW2917228280

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.